Intellia Therapeutics

Youtube Subscribe

Open: 38.0 Close: 38.04 Change: 0.04

Try an AI to get informed about investing in Intellia Therapeutics Stock.

The game is changing. There is a new strategy to evaluate Intellia Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Intellia Therapeutics are: Intellia, Therapeutics, stock, Inc, NTLA, signal, edit, …

Concept Map

Semantic Network

Stock Summary

Intellia Therapeutics Inc. (NTLA) Director Muna Bhanji sold 1,867 shares of the company in a transaction on Thursday, July 6th. Director Munani Bhanj now holds 12.

Today's Summary

Intellia Therapeutics, Inc. (NTLA) has the potential to rally 185.4% as Wall Street Analysts expect? Wall Street expects the companys stock to rise 107%. Director Muna Bhanji sold 1,867 shares of the businesss stock.

Today's News

Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the CRISPR system. Intellia Therapeutics, Inc. (NTLA) stock price today, quote & news | Seeking Alpha. Join now to see what you are missing. Morgan Stanley increased its holdings in Intellia Therapeutics by an impressive 64.5% during the fourth quarter. Norges Bank, one of the most prominent institutional investors, recently acquired a new position in the company. Revenue & collaboration accounting manager job with intellia therapeutics. Intellia Therapeutics stock price today (nasdaq: ntla) quote, market cap, chart. Intellia Therapeutics ( NASDAQ:NTLA – Get Free Report ) last released its quarterly earnings data on Thursday, August 3rd. Director Muna Bhanji sold 1,867 shares of the businesss stock in a transaction that occurred on Thursday 6th. Intellia Therapeutics stock price predictions for August 2023. Intellya Therapeutic stock predictions for next months and years. Stock predictions for September 2023, November 2023 and December 2023. Intellia Therapeutics Inc (NASDAQ: NTLA ) – Bought a combined total of 3,114 shares across different ETFs. Wall Street expects the companys stock to rise 107%. Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. Intellya Therapeutic, Inc. (NTLA) has the potential to rally 185.4% as Wall Street Analysts expect? Intellia Therapeutics stock forecast was last updated on August 29, 2023 at 13:55. NTLA stock forecast sentiment is bearish   with 2 technical analysis indicators signaling bullish signals, and 24 signaling bearish signals. NTla stock forecast for 2025: $ 72.

Stock Profile

" Intellia Therapeutics Inc. (NTLA) Director Muna Bhanji sold 1,867 shares of the company in a transaction on Thursday, July 6th. Cyndeo Wealth Partners LLC acquired a new position in Intellya Therapeutic, Inc. in Stock. Intellia Therapeutics is anticipated to post earnings of ($4.05) per share for the year. This forecast comes amidst a consensus estimate of $5.33 per share. Director Muna Bhanji now holds 12,526 shares in the company valued at $492,271. Wall Street analysts think its a good time to buy Intellia Therapeutics stock. Out of 16 sell side analysts who give forecasts on NTLA, the consensus analyst rating is a Strong Buy. NTLA does not generate passive income. Cambridge, MA, is hiring associate director, clinical data management in cambridge, massachusetts, united states. Sandia Investment Management LP acquired a new position in shares of Intellia Therapeutics in the fourth quarter valued at approximately $35,000. CWM LLC boosted its holdings in shares by 2,072.7% in the first quarter. Raymond James & Associates owns 0.06% of Intellia Therapeutics worth $1,972,000 at the end of the most recent quarter. Director Muna Bhanji sold 1,867 shares of the businesss stock in a transaction on Thursday, July 6th."

Keywords

This document will help you to evaluate Intellia Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Intellia Therapeutics are: Intellia, Therapeutics, stock, Inc, NTLA, signal, edit, and the most common words in the summary are: therapeutic, intellia, stock, inc, price, job, company, . One of the sentences in the summary was: Intellia Therapeutics, Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #intellia #stock #inc #price #job #company.

Read more →

Youtube Subscribe

---